I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Comparison of biological data between the failure and the n..:
Natsuki Ishida
;
Kenichi Takahashi
;
Yusuke Asai
...
doi:10.1371/journal.pone.0295681.t003. , 2024
Link:
https://doi.org/10.1371/journal.pone.0295681.t003
RT Journal T1
Comparison of biological data between the failure and the non-failure groups
UL https://suche.suub.uni-bremen.de/peid=base-ftunivoxfordfig:oai:figshare.com:article_24930682&Exemplar=1&LAN=DE A1 Natsuki Ishida A1 Kenichi Takahashi A1 Yusuke Asai A1 Takahiro Miyazu A1 Satoshi Tamura A1 Shinya Tani A1 Mihoko Yamade A1 Moriya Iwaizumi A1 Yasushi Hamaya A1 Satoshi Osawa A1 Ken Sugimoto YR 2024 K1 Medicine K1 Microbiology K1 Cell Biology K1 Immunology K1 Cancer K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 xlink "> anti K1 investigate serum albumin K1 738 &# 8211 K1 tumor necrosis factor K1 ifx ) K1 adalimumab K1 clinically active patients K1 biological data showed K1 adalimumab </ p K1 ulcerative colitis treated K1 ulcerative colitis K1 biological data K1 prognostic factor K1 four patients K1 uc treated K1 week 2 K1 two groups K1 therapeutic effect K1 significantly higher K1 significant difference K1 operating characteristic K1 including infliximab K1 group analysis K1 crucial position K1 confidence interval K1 advanced therapy K1 ada ) K1 999 ) K1 -&# 945 JF doi:10.1371/journal.pone.0295681.t003 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0295681.t003 DO https://doi.org/10.1371/journal.pone.0295681.t003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)